Positively Sharing

Russia’s Sputnik V vaccine has 92% efficacy in trial

Reading Time: minute

Russia’s Sputnik V coronavirus vaccine gives around 92% protection against Covid-19, late stage trial results published in The Lancet reveal.  Read More

Exit mobile version